BioSpace News Archive

Business

BioSpace Movers & Shakers: Singular Genomics, Marengo, Ventyx, Caribou and More

Life sciences and biopharma companies strengthen their leadership teams and boards with these Movers & Shakers.

May 12, 2022
·
8 min read
·
Alex Keown
Policy

Police Documents Reveal Details Of Allegations Against Seagen Founder

Police documents reveal a May 2 dated TRO against Siegall concerning a fourth degree domestic violence gross misdemeanor charge.

May 12, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

Sana’s Terry Fry to Spearhead New Regenerative, Cell & Gene Therapy Endeavor

Dr. Terry Fry, M.D., a leader in chimeric antigen receptor T-cell (CAR-T) therapies and senior vice president, head of T-cell therapeutics at Sana Biotechnology, will be heading the newly created Gates Institute.

May 12, 2022
·
2 min read
·
Mark Terry
Policy

AbbVie, Teva May Pay $5 Billion To Settle Opioid Lawsuit

AbbVie and Teva are reportedly ready to pay over $5 billion to quiet the over 3,500 opioid liability lawsuits filed against them over their painkillers.

May 12, 2022
·
2 min read
·
Vanessa Doctor, MS
Policy

Biden Commemorates 1M Lives Lost to COVID, Urges Congress to Act

On Thursday at the White House, President Biden paid tribute to the 1 million American lives lost due to COVID-19.

May 12, 2022
·
2 min read
·
Rosemary Scott
Policy

Skip to main content Enable accessibility for visually impaired Open the accessibility menu Open the Accessible Navigation Menu Accessibility Widget Occlutech Progress in US – First Patient has been Enrolled in Important US FDA Study

Occlutech Holding AG, one of the world’s leading providers of minimally invasive structural heart disease implants, continues its progress in the US market.

May 12, 2022
·
3 min read
Business

X4 Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

X4 Pharmaceuticals, a leader in the discovery and development of novel oral CXCR4-targeted small molecule therapeutics to benefit people with rare immune system disorders, reported financial results for the first quarter ended March 31, 2022.

May 12, 2022
·
9 min read
Deals

Vizient Announces Expansion of Novaplus Enhanced Supply in Med/Surg, Pharmacy

Vizient, Inc. today announced it has expanded Novaplus® Enhanced Supply to include three new medical/surgical categories and an antidotes category for pharmaceutical supplies.

May 12, 2022
·
3 min read
A novel universal antiviral drug introduced in Korea

Hyundai Bioscience announced on the 11th that phase 2 clinical trial of CP-COV03 for COVID-19 patients has begun.

May 12, 2022
·
5 min read
Business

Matinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights

Matinas BioPharma Holdings, Inc. reported financial results for the first quarter ended March 31, 2022, along with a corporate update.

May 12, 2022
·
13 min read